Repare Therapeutics Inc. (RPTX) reported Q4 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $9.72 million.
Repare Therapeutics Inc. (RPTX) reported Q4 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $9.72 million.